Navigation Links
Hemoglobin, Urine

ProductsHemoglobin, Urine
Company ARUP Laboratories
Item Hemoglobin, Urine
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Fetal Hemoglobin, Semi-Quantitative
2. Fetal Hemoglobin, APT Test
3. Hemoglobin, Plasma
4. Hemoglobin, Unstable
5. Hemoglobin, Serum
6. Clinitek 500 Urine Chemistry Analyzer
7. Clinitek Atlas Automated Urine Chemistry Analyzer (Rack)
8. Chemstrip 101 Urine Analyzer
9. Clinitek Atlas Automated Urine Chemistry Analyzer (Carousel)
10. Urisys 1100 Urine Analyzer
11. Criterion™ II Urine Analyzer
Breaking Medicine News(10 mins):Health News:Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction 2Health News:Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses 2Health News:Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses 3Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 2Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 3Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 2Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 3Health News:States Slash Funding for Tobacco Prevention Programs 2Health News:States Slash Funding for Tobacco Prevention Programs 3
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Vivakor Announces New Acquisition Strategy 2Millstone Medical Outsourcing Appoints New Leadership of Memphis Facility 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 1BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 3BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 4Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 1Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 2Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 3CBI Hosts Life Sciences Summit on International Trade Compliance 14047 1CBI Hosts Life Sciences Summit on International Trade Compliance 14047 2